The influence of age on low density lipoprotein metabolism: Effects of cholestyramine treatment in young and old healthy male subjects

Journal of Internal Medicine

Volumn 242, Issue 4, 1997, Pages 329-337

  Ericsson, S ^b   Berglund, L ^b   Frostegard J ^b   Einarsson, K ^b   Angelin, B ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Age; Bile acids; Cholesterol; Cholestyramine; LDL kinetics; LDL receptors

Indexed keywords

APOLIPOPROTEIN B; COLESTYRAMINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AGED; ARTICLE; CELL GROWTH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LIPOPROTEIN METABOLISM; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY;

EID: 0030689726     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1997.00238.x     Document Type: Article

References (36)

1. Castelli WP, Garrison RJ, Wilson WF, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA 1986; 256: 2835-8.
2. Vega GL, Grundy SM. Metabolic basis of primary hypercholesterolemia. Circulation 1991; 84: 118-28.
3. Heiss G, Tamir I, Davis CE, Tyroler HA, Rifkind BM, Schonfeld G, et al. Lipoprotein-cholesterol distributions in selected North American populations: the Lipid Research Clinics Program Prevalence Study. Circulation 1980; 61: 302-15.
4. Abbott RD, Garrison RJ, Wilson PW, Epstein FH, Castelli WP, Feinleib M, LaRue C. Joint distribution of lipoprotein cholesterol classes: the Framingham Study. Arteriosclerosis 1983; 3: 260-72.
5. Grundy SM, Vega GL, Bilheimer DW. Kinetic mechanisms determining variability in low density lipoprotein levels and rise with age. Arteriosclerosis 1985; 5: 623-30.
6. Ericsson S, Eriksson M, Vitols S, Einarsson K, Berglund L, Angelin B. Influence of age on the metabolism of plasma low density lipoproteins in healthy males. J Clin Invest 1991; 87: 591-6.
7. Brown MS, Goldstein JL. Lipoprotein receptors in the liver: control signals for plasma cholesterol traffic. J Clin Invest 1983; 72: 743-7.
8. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986; 232: 34-47.
9. Angelin B. Studies on the regulation of hepatic cholesterol metabolism in humans. Eur J Clin Invest 1995; 25: 215-24.
10. Rudling M, Reihnér E, Einarsson K, Ewerth S, Angelin B. Low density lipoprotein receptor binding activity in human tissues: quantitative importance of hepatic receptors and evidence for regulation of their expression in vivo. Proc Natl Acad Sci USA 1990; 87: 3469-73.
11. Grundy SM, Vega GL, Bilheimer DW. Causes and treatment of hypercholesterolemia. Atheroscler Rev 1986; 15: 13-39.
12. Angelin B, Einarsson K. Bile acids and lipoprotein metabolism. Atheroscler Rev 1986; 15: 41-66.
13. Einarsson K, Nilsell K, Leijd B, Angelin B. Influence of age on secretion of cholesterol and synthesis of bile acids by the liver. N Engl J Med 1985; 313: 277-82.
14. Reihnér E, Angelin B, Rudling M, Ewerth S, Björkhem I, Einarsson K. Regulation of hepatic cholesterol metabolism in humans: stimulatory effects of cholestyramine on HMG-CoA reductase activity and low density lipoprotein receptor expression in gallstone patients. J Lipid Res 1990; 31: 2219-26.
15. Levy R, Langer T. Hypolipidemic drugs and lipoprotein metabolism. Adv Exp Med Biol 1972; 26: 155-63.
16. Shepherd J, Packard CJ, Bicker S, Lawrie TDV, Morgan HG. Cholestyramine promotes receptor-mediated low-density lipoprotein catabolism. N Engl J Med 1980; 302: 1219-22.
17. Young SG, Witztum JL, Carew TE, Krauss RW, Lindgren FT. Colestipol-induced changes in LDL composition and metabolism: II. Studies in humans. J Lipid Res 1989; 30: 225-38.
18. Jungner I, Steiner E. Epidemiologisk undersökning av lipider och lipoproteiner (Epidemiological studies on lipids and lipoproteins) (Abstract.) Hygiea 1988; 97: 193.
19. Eriksson M, Berglund L, Rudling M, Henriksson P, Angelin B. Effects of estrogen on low density lipoprotein metabolism in males. Acute and chronic studies during hormonal treatment of prostatic carcinoma. J Clin Invest 1989; 84: 802-10.
20. Kesäniemi YA, Grundy SM. The significance of low density lipoprotein production in the regulation of plasma cholesterol level in man. J Clin Invest 1982; 70: 13-22.
21. McFarlane AS. Efficient trace-labeling of proteins with iodine. Nature 1958; 182: 53.
22. Bilheimer DW, Eisenberg S, Levy RI. The metabolism of very low density lipoproteins: I. Preliminary in vitro and in vivo observations. Biochim Biophys Acta 1972; 260: 212-21.
23. Lowry O, Rosebrough N, Farr A, Randall R. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-75.
24. Bartlett G. Phosphorus assay in column chromatography. J Biol Chem 1958; 234: 466-8.
25. Matthews CME. The theory of tracer experiments with iodine 131-labeled plasma proteins. Phys Med Biol 1957; 2: 36-53.
26. Langer T, Strober W, Levy RI. The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia. J Clin Invest 1972; 51: 1528-36.
27. Frostegârd J, Hamsten A, Gidlund M, Nilsson J. Low density lipoprotein-induced growth of U 937 cells - novel method to determine the receptor binding of low density lipoprotein. J Lipid Res 1990; 31: 37-44.
28. Witztum JL, Schonfeld G, Weidman SW. The effects of colestipol on the metabolism of very low density lipoproteins in man. J Lab Clin Med 1976; 88: 1008-18.
29. Witztum JL. Schonfeld G. Weidman SW, Giese WE, Dillingham MA. Bile acid sequestrant therapy alters the composition of low density and high density lipoproteins. Metabolism 1979; 28: 221-9.
30. Witztum JL, Young SG, Elam RL, Carew TE, Fischer M. Cholestyramine-induced changes in low density lipoprotein composition and metabolism: I. Studies in the guinea pig. J Lipid Res 1985; 26: 92-102.
31. Eriksson M, Angelin B, Henriksson P, Ericsson S, Vitols S, Berglund L. Metabolism of lipoprotein remnants in humans: studies during intestinal infusion of fat and cholesterol in subjects with varying expression of the low density lipoprotein receptor. Arteriosclerosis and Thrombosis 1991; 11: 827-37.
32. Angelin B, Einarsson K, Hellström K, Leijd B. Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoproteinemia. J Lipid Res 1978; 19: 1017-24.
33. Beil U, Crouse JR, Einarsson K, Grundy SM. Effects of interruption of the enterohepatic circulation of bile acids on the transport of very low density lipoprotein triglycerides. Metabolism 1982; 31: 438-44.
34. Angelin B, Leijd B, Hultcrantz R, Einarsson K. Increased turnover of very low density lipoprotein triglyceride during treatment with cholestyramine in familial hypercholesterolaemia. J Intern Med 1990; 227: 201-6.
35. Kleinman Y, Eisenberg S, Schry YO, Gavish D, Stein O, Stein Y. Defective metabolism of hypertriglyceridemic low density lipoprotein in cultured human fibroblasts. Normalization with bezafibrate therapy. J Clin Invest 1985; 75: 1796-803.
36. Aviram M, Lund-Katz S, Phillips MC, Chait A. The influence of the triglyceride content of low density lipoprotein on the interaction of apolipoprotein B-100 with cells. J Biol Chem 1988; 263: 16842-8.